The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Kristin Daly has no relevant financial relationships to disclose. Kathryn Slane has no relevant financial relationships to disclose.
Learning Objectives:
Recall current standard-of-care treatments in head and neck squamous cell carcinoma (HNSCC)
Discuss clinical trials involving immunotherapy in both curative and palliative settings for HNSCC non-nasopharyngeal cancers (non-NPC)
Identify predictive and prognostic biomarkers with clinical implications in head and neck cancers
Anticipate side effects commonly associated with these various therapies
Speaker(s):
Kristin
Daly,
Nurse Practitioner,
Washington University School of Medicine
Kathryn
E. Slane,
Advanced Oncology Certified Nurse Practitioner,
Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine
You must be logged in and own this session in order to
post comments.